To compare the efficacy Of raktavasechana ( jalaukavacharana ) and manjistha lepa On facial blemishes.
- Conditions
- Health Condition 1: L811- ChloasmaHealth Condition 2: L599- Disorder of the skin and subcutaneous tissue related to radiation, unspecified
- Registration Number
- CTRI/2023/08/056716
- Lead Sponsor
- Shri Krishna Government Ayurvedic College and Hospital kurukshetra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients presenting with classical signs and symptoms of vyanga were selected.
2. Age groups between 16-60 years were selected.
3. Both the sex.
4. Chronicity less than 2 years
5. Patients yogya for Lepa and raktavsechana.
6. Patient willing to sign the consent form.
7. Patient not taking any other medicine for Hyperpigmentation.
8. Patient with classical symptoms of vyanga.
1. Patients ayogya for Lepa and raktavsechana.
2. Malignant melanoma
3. Acne Vulgaris,riehls melanosis, Poikiloderma of civtte.
4. Patients with other Systemic disorders.
5. Severe Anemia, pregnancy, any kind of noted drug allergy
6. Patient below the age 16 year and above 60 years.
7. Patient with Leprosy, Tuberculosis and Paralysis.
8. Hyperpigmentation caused due to any systemic disease such as Addisons disease,
Cushing syndrome and Systemic lupus erythematous.
9. Patient with uncontrolled Hypertension/Cardiac problem/Diabetes Mellitus and any
systematic disorder.
10. Hyperpigmentation since birth like Nevus of Ota and those caused by tumors such
as malignant melanoma.
11. Exogenous ochronosis is a cutaneous disorder characterized by blue-black
pigmentation resulting as a complication of long term application of skin
lightening creams containing hydroquinone.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The outcome will be assessed on basis of improvement in MASI SCORE.Timepoint: At the baseline 30th & 60th day.
- Secondary Outcome Measures
Name Time Method The outcome will be assessed on basis of improvement in sign & lesion color through color grading scale.Timepoint: at the baseline 30th & 60th day.